A Study of Chemotherapy Treatment for Patients With Ovarian Cancer

Clinical trial NCT00428610 · COMPLETED

Trial details

NCT number: NCT00428610
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2007-02-01
Primary completion: 2011-02-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.